- Home
- GLMD vs SBFM Comparison
GLMD vs SBFM Comparison
Compare GLMD & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- SBFM
- Stock Information
- Founded
- GLMD 2000
- SBFM 2006
- Country
- GLMD Israel
- SBFM United States
- Employees
- GLMD N/A
- SBFM N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- GLMD Health Care
- SBFM Health Care
- Exchange
- GLMD Nasdaq
- SBFM Nasdaq
- Market Cap
- GLMD 8.0M
- SBFM 6.7M
- IPO Year
- GLMD 2014
- SBFM N/A
- Fundamental
- Price
- GLMD $1.59
- SBFM $1.67
- Analyst Decision
- GLMD Hold
- SBFM Strong Buy
- Analyst Count
- GLMD 1
- SBFM 1
- Target Price
- GLMD N/A
- SBFM $15.00
- AVG Volume (30 Days)
- GLMD 81.5K
- SBFM 62.2K
- Earning Date
- GLMD 11-13-2025
- SBFM 11-04-2025
- Dividend Yield
- GLMD N/A
- SBFM N/A
- EPS Growth
- GLMD N/A
- SBFM N/A
- EPS
- GLMD N/A
- SBFM N/A
- Revenue
- GLMD N/A
- SBFM $36,341,741.00
- Revenue This Year
- GLMD N/A
- SBFM $32.20
- Revenue Next Year
- GLMD N/A
- SBFM $32.74
- P/E Ratio
- GLMD N/A
- SBFM N/A
- Revenue Growth
- GLMD N/A
- SBFM 19.22
- 52 Week Low
- GLMD $1.15
- SBFM $1.17
- 52 Week High
- GLMD $4.81
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- GLMD 58.87
- SBFM 67.82
- Support Level
- GLMD $1.35
- SBFM $1.50
- Resistance Level
- GLMD $1.63
- SBFM $1.67
- Average True Range (ATR)
- GLMD 0.09
- SBFM 0.08
- MACD
- GLMD 0.02
- SBFM 0.01
- Stochastic Oscillator
- GLMD 76.67
- SBFM 73.44
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.